Nobody Is Going To Be Spared: FDA’s Tukaram Mundhe Issues Strict Warning Amid Notices To SRK, Ajay & Tiger
Vimal Elaichi Advertisement Controversy: Maharashtra FDA warns Shah Rukh Khan, Ajay Devgn and Tiger Shroff over surrogate Pan Masala advertising.
Nobody Is Going To Be Spared: Maharashtra FDA’s Tukaram Mundhe Issues Strict Warning Amid Notices To Shah Rukh Khan, Ajay Devgn & Tiger Shroff Over Vimal Elaichi Advertisement Controversy And Surrogate Advertising Of Pan Masala
The Vimal Elaichi Advertisement Controversy has once again brought celebrity endorsements and surrogate advertising into the spotlight. Bollywood stars Shah Rukh Khan, Ajay Devgn and Tiger Shroff have reportedly received notices from the Maharashtra FDA over their association with advertisements for Vimal Elaichi. The regulator is examining whether the campaign indirectly promotes products associated with Pan Masala and tobacco-related products.
The issue has attracted considerable public attention because these advertisements use the same recognizable branding associated with Vimal while presenting elaichi as the advertised product. The Maharashtra FDA’s action has therefore raised broader questions about how brands and celebrities should approach advertising when a product name is closely connected with products subject to restrictions.
Tukaram Mundhe Sends A Strong Message
Maharashtra FDA chief Tukaram Mundhe has adopted a firm position on the matter. According to reports, he said that responsibility would apply across the advertising chain and warned that “nobody is going to be spared” if violations are established. He also emphasized that advertising claims and endorsements must comply with applicable FSSAI guidelines and regulations.
The warning is significant because it suggests that the regulator is not looking only at the celebrities appearing in an advertisement. The wider question involves the brand, advertising strategy and everyone involved in creating or promoting potentially misleading campaigns. Any final action, however, would depend on the findings of the regulatory process.
Why Shah Rukh Khan, Ajay Devgn And Tiger Shroff Received Notices
The notices have put three of Bollywood’s biggest stars under scrutiny. Shah Rukh Khan, Ajay Devgn and Tiger Shroff appeared together in a Vimal Elaichi campaign, with Tiger joining the long-running association of the other two actors with the brand. Tiger’s inclusion followed Akshay Kumar’s earlier withdrawal from the campaign after facing public criticism over the endorsement.
The central issue is not simply whether elaichi itself contains tobacco. Instead, regulators are examining whether advertising a related product under the same brand identity can function as Surrogate Advertising for a restricted or prohibited product. This distinction is at the heart of the current controversy.
What Is Surrogate Advertising?
Surrogate advertising generally refers to promoting a product or brand indirectly when direct advertising of the associated product is restricted. In this case, the debate centers on whether an advertisement for Vimal Elaichi can reinforce consumer recognition of the wider Vimal brand and, indirectly, products associated with Pan Masala.
Such advertising has been debated in India for years. Celebrity-led campaigns can make the issue even more prominent because actors have enormous reach and influence. Previous Vimal campaigns featuring major Bollywood stars have repeatedly generated public discussion around the boundaries between legitimate product promotion and indirect brand promotion.
Vimal Elaichi Advertisement Controversy Is Not New
The latest development is part of a longer-running debate. Vimal’s celebrity advertisements have featured some of India’s most recognizable actors. In 2022, Akshay Kumar faced substantial criticism for his association with the brand and subsequently announced that he was stepping away from the endorsement. He also said his endorsement fee would be directed toward charity.
The controversy returned when advertisements featuring Shah Rukh Khan, Ajay Devgn and later Tiger Shroff appeared. The campaigns generated both humorous reactions and criticism online, with some viewers questioning whether influential celebrities should associate themselves with brands linked in public perception to potentially harmful products.
Read more: From Smriti Irani To Pasmanda Outreach: BJP’s UP 2027 Game Plan In Nitin Nabin’s New Team
Celebrity Endorsements Under Greater Scrutiny
The Maharashtra FDA’s latest move could intensify the conversation about celebrity responsibility in advertising. Actors are frequently selected by brands because their popularity can increase visibility, recognition and consumer engagement. However, the same influence can lead to greater scrutiny when the advertised category is controversial.
For celebrities, the controversy highlights the importance of examining not only the exact product mentioned in a contract but also how the brand is positioned, marketed and perceived by consumers. For regulators, the challenge is determining whether an advertisement complies with the applicable legal and food-safety framework.
What Happens Next?
The notices issued to Shah Rukh Khan, Ajay Devgn and Tiger Shroff do not automatically establish wrongdoing. They provide an opportunity for the concerned parties to respond and for authorities to examine the facts, advertising material and relevant documentation. The Maharashtra FDA can determine what further action, if any, is appropriate after reviewing the responses and evidence.
Read more: Devendra Mahto Ends 16-Day Hunger Strike After Jharkhand Cancels JSSC-CGL, Calls It ‘Huge Victory’
Meanwhile, the strong statement from Tukaram Mundhe has made the regulator’s position clear: advertising practices will be closely examined, and celebrities as well as other parties involved in an endorsement may face scrutiny when regulations are allegedly breached.
Conclusion
The Vimal Elaichi Advertisement Controversy has once again placed Shah Rukh Khan, Ajay Devgn and Tiger Shroff at the center of a debate over celebrity endorsements and Surrogate Advertising. With the Maharashtra FDA taking a firm stance, the case could become an important example of how regulators approach advertising for products whose branding is closely associated with Pan Masala or tobacco-related categories. For now, the notices mark a regulatory inquiry rather than a final finding, but Tukaram Mundhe’s “nobody is going to be spared” warning indicates that Maharashtra authorities intend to examine the matter seriously.
We’re now on WhatsApp. Click to join.
Like this post?
Register at One World News to never miss out on videos, celeb interviews, and best reads.







